Mehta Vimal
BioXcel Therapeutics, Inc. · CEO and President
Mehta Vimal is listed in filings as CEO and President at BioXcel Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to BioXcel Therapeutics, Inc. (BTAI). The current snapshot covers public activity from Jun 18, 2024 to May 22, 2026. Reported amounts are shown as $21.1K to $773. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $7732.1k shares | SellDec 16, 2024 | $0.3624 | $1.26 | |
| $358983 shares | SellDec 16, 2024 | $0.3641 | $1.26 | |
| $7941.2k shares | SellSep 16, 2024 | $0.6905 | $1.26 | |
| $573832 shares | SellSep 16, 2024 | $0.6885 | $1.26 | |
| $2.7k2.1k shares | SellJun 17, 2024 | $1.28 | $1.26 |